Literature DB >> 22531842

Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors.

David P Martin1, Seth M Cohen.   

Abstract

A series of hydroxybenzoic acid derivatives have shown inhibitory activity against carbonic anhydrase (CA). X-ray crystallography shows that these molecules inhibit not by binding the active site metal ion but by strong hydrogen bonding to the metal-bound water nucleophile. The binding mode observed for these molecules is distinct when compared to other non-metal-binding CA inhibitors. This journal is © The Royal Society of Chemistry 2012

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22531842      PMCID: PMC3674230          DOI: 10.1039/c2cc32013d

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  25 in total

1.  Using model complexes to augment and advance metalloproteinase inhibitor design.

Authors:  Faith E Jacobsen; Seth M Cohen
Journal:  Inorg Chem       Date:  2004-05-17       Impact factor: 5.165

2.  Identifying chelators for metalloprotein inhibitors using a fragment-based approach.

Authors:  Jennifer A Jacobsen; Jessica L Fullagar; Melissa T Miller; Seth M Cohen
Journal:  J Med Chem       Date:  2010-12-28       Impact factor: 7.446

3.  Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site.

Authors:  Serdar Durdagi; Murat Şentürk; Deniz Ekinci; Halis Türker Balaydın; Süleyman Göksu; Ö İrfan Küfrevioğlu; Alessio Innocenti; Andrea Scozzafava; Claudiu T Supuran
Journal:  Bioorg Med Chem       Date:  2011-01-14       Impact factor: 3.641

4.  Carbonic anhydrase inhibitors: Inhibition of human erythrocyte isozymes I and II with a series of phenolic acids.

Authors:  S Beyza Oztürk Sarikaya; Ilhami Gülçin; Claudiu T Supuran
Journal:  Chem Biol Drug Des       Date:  2010-05       Impact factor: 2.817

5.  Esterase activities of human carbonic anhydrases B and C.

Authors:  J A Verpoorte; S Mehta; J T Edsall
Journal:  J Biol Chem       Date:  1967-09-25       Impact factor: 5.157

6.  In vitro inhibition of α-carbonic anhydrase isozymes by some phenolic compounds.

Authors:  Sevim Beyza Oztürk Sarikaya; Fevzi Topal; Murat Sentürk; Ilhami Gülçin; Claudiu T Supuran
Journal:  Bioorg Med Chem Lett       Date:  2011-05-25       Impact factor: 2.823

7.  Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids.

Authors:  Alessio Innocenti; S Beyza Öztürk Sarıkaya; İlhami Gülçin; Claudiu T Supuran
Journal:  Bioorg Med Chem       Date:  2010-02-06       Impact factor: 3.641

8.  In Vitro inhibition of human carbonic anhydrase I and II isozymes with natural phenolic compounds.

Authors:  Murat Sentürk; Ilhami Gülçin; Sükrü Beydemir; O İrfan Küfrevioğlu; Claudiu T Supuran
Journal:  Chem Biol Drug Des       Date:  2011-03-25       Impact factor: 2.817

Review 9.  Human carbonic anhydrases and carbonic anhydrase deficiencies.

Authors:  W S Sly; P Y Hu
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

10.  New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups.

Authors:  David T Puerta; Jana A Lewis; Seth M Cohen
Journal:  J Am Chem Soc       Date:  2004-07-14       Impact factor: 15.419

View more
  17 in total

1.  Metalloprotein-inhibitor binding: human carbonic anhydrase II as a model for probing metal-ligand interactions in a metalloprotein active site.

Authors:  David P Martin; Zachary S Hann; Seth M Cohen
Journal:  Inorg Chem       Date:  2013-05-24       Impact factor: 5.165

2.  Homology models of mouse and rat estrogen receptor-α ligand-binding domain created by in silico mutagenesis of a human template: molecular docking with 17ß-estradiol, diethylstilbestrol, and paraben analogs.

Authors:  Thomas L Gonzalez; James M Rae; Justin A Colacino; Rudy J Richardson
Journal:  Comput Toxicol       Date:  2018-11-28

3.  Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1.

Authors:  Allie Y Chen; Pei W Thomas; Alesha C Stewart; Alexander Bergstrom; Zishuo Cheng; Callie Miller; Christopher R Bethel; Steven H Marshall; Cy V Credille; Christopher L Riley; Richard C Page; Robert A Bonomo; Michael W Crowder; David L Tierney; Walter Fast; Seth M Cohen
Journal:  J Med Chem       Date:  2017-08-30       Impact factor: 7.446

4.  When Does Chemical Elaboration Induce a Ligand To Change Its Binding Mode?

Authors:  Shipra Malhotra; John Karanicolas
Journal:  J Med Chem       Date:  2016-12-16       Impact factor: 7.446

5.  Investigating the selectivity of metalloenzyme inhibitors.

Authors:  Joshua A Day; Seth M Cohen
Journal:  J Med Chem       Date:  2013-10-14       Impact factor: 7.446

6.  Benzofuran-Based Carboxylic Acids as Carbonic Anhydrase Inhibitors and Antiproliferative Agents against Breast Cancer.

Authors:  Wagdy M Eldehna; Alessio Nocentini; Zainab M Elsayed; Tarfah Al-Warhi; Nada Aljaeed; Ohoud J Alotaibi; Mohammad M Al-Sanea; Hatem A Abdel-Aziz; Claudiu T Supuran
Journal:  ACS Med Chem Lett       Date:  2020-03-18       Impact factor: 4.345

7.  Carbonic anhydrase II in complex with carboxylic acid-based inhibitors.

Authors:  Carrie L Lomelino; Robert McKenna
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2019-02-20       Impact factor: 1.056

8.  Investigating the Selectivity of Metalloenzyme Inhibitors in the Presence of Competing Metalloproteins.

Authors:  Yao Chen; Seth M Cohen
Journal:  ChemMedChem       Date:  2015-08-25       Impact factor: 3.466

9.  Isosteres of hydroxypyridinethione as drug-like pharmacophores for metalloenzyme inhibition.

Authors:  Rebecca N Adamek; Cy V Credille; Benjamin L Dick; Seth M Cohen
Journal:  J Biol Inorg Chem       Date:  2018-07-12       Impact factor: 3.358

10.  'Unconventional' coordination chemistry by metal chelating fragments in a metalloprotein active site.

Authors:  David P Martin; Patrick G Blachly; Amy R Marts; Tessa M Woodruff; César A F de Oliveira; J Andrew McCammon; David L Tierney; Seth M Cohen
Journal:  J Am Chem Soc       Date:  2014-03-27       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.